Módulo 1
Mecanismos
Alteração de permeabilidade
Alteração do sítio de ação
Bomba de efluxo
Mecanismo enzimático
Gram-positivos
Staphylococcus aureus
Enterococcus spp.
Streptococcus pneumoniae
Gram-negativos
Aminoglicosídeos
Quinolonas
β-lactâmicos
Carbapenens
Bibliografia
Antimicrobianos - Base Teóricas e Uso Clínico

IV. Bibliografia consultada

  1. Bradford PA. Extended-spectrum β-lactamases in the 21st century: characterization, epidemiology, and detection of this important resistance threat. Clin Microbiol Rev. 2001; 14(4):933-51. Acessível em: http://cmr.asm.org/cgi/reprint/14/4/933

  2. Bush K, Jacoby GA, Medeiros AA. A functional classification scheme for beta-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995; 39(6):1211-33. Acessível em: http://aac.asm.org/cgi/reprint/39/6/1211

  3. Furtado GH, Martins ST, Coutinho AP, Soares GM, Wey SB, Medeiros EA. Incidence of vancomycin-resistant Enterococcus at a university hospital in Brazil. Rev Saúde Pública. 2005;39 (1): 41-6. Acessível em: http://www.scielo.br/pdf/rsp/v39n1/06.pdf

  4. Hiramatsu K, Hanaki H, Ino T, Yabuta K, Oguri T, Tenover FC. Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility. J Antimicrob Chemother 1997; 40: 135-136. Acessível em: http://jac.oxfordjournals.org/cgi/reprint/40/1/135

  5. Jacoby GA. Mechanisms of resistance to quinolones. Clin Infect Dis. 2005 Jul 15;41 Suppl 2:S120-6. Acessível em: http://www.journals.uchicago.edu/CID/journal/issues/v41nS2/34937/34937.web.pdf

  6. Livermore DM, Winstanley TG, Shannon KP. Interpretative reading: recognizing the unusual and inferring resistance mechanisms from resistance phenotypes. J Antimicrob Chemother. 2001; Jul;48 Suppl 1:87-102. Acessível em  http://jac.oxfordjournals.org/cgi/reprint/48/suppl_1/87

  7. Nikaido H. Porins and specific diffusion channels in bacterial outer membranes. J Biol Chem. 1994;269(6):3905-8. Acessível em: http://www.jbc.org/cgi/reprint/269/6/3905

  8. Rice LB. Antimicrobial resistance in gram-positive bacteria. Am J Med. 2006; 119(6A):S11-19. Clique aqui para acessar o texto.

  9. Rubin RJ, Harrington CA, Poon A, Dietrich K, Greene JÁ, Moiduddin A. The economic impact of Staphylococcus aureus infection in New York City hospitals. Emerg Infect Dis 1999; 5:9-17. Acessível em: http://www.cdc.gov/ncidod/eid/vol5no1/pdf/v5n1.pdf

  10. Brandileone MCC, Casagrande ST, Maria-Luiza L, Guerra S, Rosemeire CZ, Ana-Lucia S, Andrade S de, e Di Fabio JL. Increase in numbers of ß-lactam-resistant invasive Streptococcus pneumoniae in Brazil and the impact f conjugate vaccine coverage. Journal of Medical Microbiology (2006): 55, 567-574. Acessível em: http://jmm.sgmjournals.org/cgi/reprint/55/5/567

  11. Camargos P, Fischer GB, Mocelin H, Dias C e Ruvinsk R. Penicillin  resistance and serotyping of Streptococcus pneumoniae in Latin America. Pediatric Respiratory Reviews. September 2006; Volume 7; 209-214.  Clique aqui para acessar o texto.

  12. Carvalhanas TRMP, Brandileone MCC, Zanella RC. Meningites Bacterianas. Boletim Epidemiológico Paulista, maio 2005; 17(2): 15-27. Acessível em: ftp://ftp.cve.saude.sp.gov.br/doc_tec/outros/bol_bepa1705.pdf

  13. CLSI. Performance standards for antimicrobial disk susceptibility testing. Approved standard M100-S17, 17th ed. 2007.Clinical and Laboratory Standards Institute, Wayne, Pa. Acessível em: http://www.nccls.org/ 


« voltar 1
   
RMcontrole. 2007